Disruption of the Circadian Clock Alters Antioxidative Defense via the SIRT1-BMAL1 Pathway in 6-OHDA-Induced Models of Parkinson’s Disease

Figure 6

BMAL1 and CRY1 binding was increased after 6-OHDA treatment, which was reversed by SIRT1 agonist.